[1]
|
J. B. Jonas, I. Kreissig and R. Degenring, “Intravitreal Triamcinolone Acetonide for Treatment of Intraocular Proliferative, Exudative, and Neovascular Diseases,” Progress in Retinal and Eye Research, Vol. 24, No. 5, 2005, pp. 587-611. doi:10.1016/j.preteyeres.2005.01.004
|
[2]
|
P. Massin, F. Audren, B. Haouchine, et al., “Intravitreal Triamcinolone Acetonide for Diabetic Diffuse Macular Edema: Preliminary Results of a Prospective Controlled Trial,” Ophthalmology, Vol. 111, No .2, 2004 pp. 218-224.
|
[3]
|
C. H. Park, G. J. Jaffe and S. Fekrat, “Intravitreal Triamcinolone Acetonide in Eyes with Cystoid Macular Edema Associated with Central Retinal Vein Occlusion,” American Journal of Ophthalmology, Vol. 136, No. 3, 2003, pp. 419-425. doi:10.1016/S0002-9394(03)00228-9
|
[4]
|
J. B. Jonas, “Intra-vitreal Triamcinolone Acetonide: A Change in a Paradigm,” Ophthalmic Research, Vol. 38, No. 4, 2006, pp. 218-245. doi:10.1159/000093796
|
[5]
|
A. Jain, M. R. Vishwanath and S. J. Charles, “Triamcinolone PseudoCataract,” Annals of Ophthalmology, Vol. 38, No. 1, 2006, pp. 67-68. doi:10.1385/AO:38:1:67
|
[6]
|
Y. B. Sakalar, K. Unlu, U. Keklikci, et al., “Persistent Triamcinolone Acetonide Particles on the Posterior Lens Capsule after Intravitreal Injection,” Annals of Ophthalmology, Vol. 40, No. 3-4, 2008, pp. 190-192.
|
[7]
|
H. Hosseini, H. R. Anvari-Ardakani, et al., “Ultrasonographic Pictures of Intravitreal Triamcinolone Acetonide,” European Journal of Ophthalmology, Vol. 19, No. 2, 2009, pp. 263-267.
|
[8]
|
L. Cheng, A. S. Banker, M. Martin, et al., “Triamcinolone Acetonide Concentration of Aqueous Humor after Decanted 20-Mg Intravitreal Injection,” Ophthalmology, Vol. 116, No. 7, 2009, pp.1356-1359.
|